Get early access! Join the Twelve Data AI Assistant waitlist now.
6.5 EUR
0
0%
Last update Sep 4, 7:31 PM CEST
Main market
Day range
6.5
6.5
Previous close
6.5
Open
6.5
Access this stock data via API
Subscribe
Innocan Pharma Corporation
6.50
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 25.1M 2.6M 196K
Cost of revenue 2.8M 452K 75K
Gross profit 22.4M 2.1M 121K
Operating expense
Research & development 1.3M 1.5M 1.4M
Selling general and admin 22.1M 6.8M 6.2M
Other operating expenses
Operating income -1.1M -6.3M -7.5M
Non operating interest income
Income 0 21K
Expense 6.0K 2K 13K
Other income expense 1.9M 2.4M -2.6M
Pretax income 784.6K -3.9M -10.1M
Tax provision 1.0M 1K 0
Net income -223.7K -3.9M -10.1M
Basic EPS 0.0 0.0 0.0 -0.1
Diluted EPS 0.0 0.0 0.0 -0.1
Basic average shares 239.1M 277.2M 259.1M 233.7M
Diluted average shares 239.1M 277.2M 259.1M 233.7M
EBITDA -1.0M -6.2M -7.4M
Net income from continuing op. -223.7K -3.9M -10.1M
Minority interests -1.6M 125K 44K
Preferred stock dividends
Main market

Exchange is currently active.
Closing in 6 hours 22 minutes

13:38
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CEST, UTC+02:00).